Pharmacists

meRfi® Microbiome for Pharmacists:

Pharmacies have a strong interest in probiotics and prebiotics as an OTC counseling area with high patient demand and economic relevance; FMT and the microbiome are perceived more as specialist background knowledge and a bridge to medical therapy. For many patients, pharmacies are the first point of contact for probiotics—e.g., during antibiotic therapy, diarrhea, irritable bowel symptoms, or questions about the immune system or “well‑being.” Many pharmacists frequently recommend probiotics, yet recognize knowledge gaps regarding mechanisms of action, strain‑specific evidence, and clear indication boundaries.

• What is needed is qualified, evidence‑based counseling on:
  Benefits, risks, and interactions of pro‑ and prebiotics (e.g., with antibiotics or immunosuppressive drugs)
• Realistic expectation management regarding marketing claims
• Appropriate positioning of prebiotics within the context of diet, constipation, IBS, and metabolic risk factors

In light of the microbiome boom, demand for “gut flora products” and microbiome tests is growing. Pharmacies increasingly see their role in distinguishing credible from unreliable offers and in advising patients on indication‑specific, dosed biotics strategies (product, duration, dose) while warning them against exaggerated promises and unnecessary microbiome tests.

The curated, continuously updated evidence base on the gut microbiota and related health topics provides the complete scientific context in a modern, encyclopedia‑style format—including citations, study details, and structured summaries—and thus supports medication counseling, patient information, and drug safety.

From the content

Microbiome medicine: Probiotics, prebiotics, synbiotics, postbiotics, genetically engineered microbes, fecal microbiota transplantation (FMT), microbial ecosystem therapeutics (MET)

The most popular manipulators of the intestinal microbiota are introduced

Probiotics impact both intestinal and extraintestinal diseases

More than 100 medical conditions are covered

Prebiotics impact both intestinal and extraintestinal diseases

More than 50 medical conditions are covered

How cancer treatment can be improved by fecal microbiota transplants, prebiotics, probiotics, and engineered microbial organisms

It covers the reduction of adverse events of cancer therapy and the improvement of its efficacy

The composition of the gut microbiota can be affected by drugs, and vice versa, the gut microbiota can impact an individual's response to a drug by enzymatically modifying the drug's structure, which in turn can change its bioavailability, bioactivity, or toxicity (parmacomicrobiomics)

The interaction between gut microbes and commonly used non-antibiotic drugs is complex and bidirectional.

The alterations in gut microbiota caused by frequently used non-antibiotic medications, along with their possible clinical outcomes, and a summary of how the microbiome influences drug efficacy

The microbiome's ability to metabolize drugs and diminish treatment efficacy opens up the potential to adjust the gut microbiome for enhanced treatment outcomes

... and more

Try now for free!